News search

Keyword

Locations

News type

Sectors

Services

Transformations

OC Ventures

Osborne Clarkes advises Imperial spinout Siftr Bio aiming to improve the precision of ADC cancer therapies

10/03/2025

• 1 min

Osborne Clarke advises Hestia IM on the acquisition of the 23 Taitbout and 134 Faubourg Saint-Honoré buildings

10/03/2025

• 1 min

Energy and Energy Transition

Intellectual property

Victory for Osborne Clarke client Avanci in Court of Appeal today

07/03/2025

• 1 min

Corporate

Osborne Clarke advised on the sale of the Caesar Augustus luxury hotel in Capri

06/03/2025

• 1 min

Osborne Clarke strengthens its stock corporation and capital market law practice with Dr Alexander Thomas

05/03/2025

• 1 min

Legal Notice

When you read about Osborne Clarke on this site, we are either referring to our international organisation, Osborne Clarke Verein (OCV), or one of its member firms. OCV is a Swiss verein and doesn’t provide services to clients. The OCV member firms are all separate legal entities and have no authority to obligate or bind each other or OCV with regard to third parties. To find out more, please click here.

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

News search

Osborne Clarkes advises Imperial spinout Siftr Bio aiming to improve the precision of ADC cancer therapies

Osborne Clarke advises Hestia IM on the acquisition of the 23 Taitbout and 134 Faubourg Saint-Honoré buildings

Osborne Clarke advises NORD/LB on EUR 86.5 million German BESS financing

Osborne Clarke advises Swarco on the acquisition of Lacroix City

Scam communications and Osborne Clarke

Victory for Osborne Clarke client Avanci in Court of Appeal today

Osborne Clarke advised on the sale of the Caesar Augustus luxury hotel in Capri

Osborne Clarke strengthens its stock corporation and capital market law practice with Dr Alexander Thomas

Sign up for our newsletter

Legal Notice